Assurance Services
Tax Consulting
Consulting ServicesPharmacy Benefits Consulting
At Blue & Co., LLC we are uncommonly independent with a unique and customized approach to find clients the best solution based solely on their goals and objectives and not our sales or revenue goals.
Our team is comprised of pharmacists who have been exposed to all sides of the pharmacy supply chain and work to bring that unique perspective to our clients. Our independent approach allows us to work with all PBMs, both big and small, to find the best solution for the client and their employees.
Meet Our Pharmacy Benefits Expert
Chad Downing RPH,340B ACE, Senior Pharmacy Consultant
Chad Downing is a Senior Pharmacy Consultant with Blue & Co., specializing in pharmacy reimbursements and operations performance. Throughout his 20-year career as a healthcare and pharmacy executive, he has been recognized as a proven leader in operational and financial performance.
Chad earned his Bachelor of Science degree in pharmacy from Ohio Northern University. He obtained his EMBA from the Quantic School of Business and Technology. He maintains active pharmacy licenses in Illinois, Indiana, Kentucky and Ohio. Six Sigma Greenbelt certified. He holds an Apexus Advanced 340B Operations Certificate.
Services Overview
Blue & Co.’s Pharmacy Consulting Group uses a data-driven approach to provide a holistic picture of pharmacy spend in both pharmacy and medical venues. With a heavy focus on internal education during phase one of our contracts, we maximize your time with us by making sure we all have the same base level understanding from day one.
Client Education
From day one, we provide client education to help you fully understand the pharmacy supply chain.
Contract Review
Our team will analyze your Pharmacy Benefit Manager contract terms and rates.
Vendor Management
Our team of experts can work hand-in-hand with you and your PBM to ensure proper day-to-day performance and help with long term RFP support.
Claims Analysis
A comprehensive review for savings opportunities through variable copay, movement to lower cost/higher quality pharmacy channel, ensure proper payment terms based on contract definitions, and removal of non-essential drugs from plan formulary.
Related Articles View All Thought Leadership
July 17, 2023
On Friday July 7th, 2023, CMS released a proposed rule outlining a plan to correct and reverse the 340B payment cuts from calendar years (CY) 2018 through 2022. This proposed rule is in response to last years Supreme Court ruling that CMS lacked authority to reduce reimbursement for drugs to average sale price (ASP) minus […]
December 15, 2022
Great news for 340B hospitals impacted by the reimbursement reductions initiated by the Center for Medicare and Medicaid Services (CMS) on January 1, 2018. Recently, CMS announced that the 2023 Medicare outpatient payment rates will be restored to rates prior to 2018 for affected hospitals. After many legal debates, court filings, and outcry from hospitals […]
July 27, 2022
In June, the Supreme Court gave hospitals participating in the 340B Drug Pricing Program a convincing victory ruling unanimously that the U.S. Center for Medicare & Medicaid Services (CMS) should not have reduced reimbursement for covered outpatient prescription drugs purchased by those hospitals. 340B Hospitals Challenge Payment Rates Hospitals challenged the 2018 and 2019 payment […]
Connect with our team.
To learn more about our services and areas of expertise, send us a message.
